PP
TMO icon

PDS Planning’s Thermo Fisher Scientific TMO Stock Holding History

PDS Planning’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Buy
3,173
+133
+4% +$72.2K 0.1% 94
2025
Q4 		$1.76M Buy
3,040
+62
+2% +$35.1K 0.12% 82
2025
Q3 		$1.44M Buy
2,978
+112
+4% +$52.1K 0.1% 88
2025
Q2 		$1.16M Sell
2,866
-141
-5% -$59K 0.09% 109
2025
Q1 		$1.5M Buy
3,007
+209
+7% +$113K 0.13% 76
2024
Q4 		$1.46M Buy
2,798
+507
+22% +$279K 0.13% 75
2024
Q3 		$1.42M Buy
2,291
+89
+4% +$52.7K 0.13% 77
2024
Q2 		$1.22M Buy
2,202
+117
+6% +$67K 0.12% 76
2024
Q1 		$1.21M Buy
2,085
+47
+2% +$26.4K 0.13% 73
2023
Q4 		$1.08M Buy
2,038
+7
+0.3% +$3.39K 0.12% 75
2023
Q3 		$1.03M Buy
2,031
+3
+0.1% +$1.6K 0.13% 75
2023
Q2 		$1.06M Sell
2,028
-343
-14% -$185K 0.14% 73
2023
Q1 		$1.37M Buy
2,371
+828
+54% +$467K 0.19% 61
2022
Q4 		$850K Sell
1,543
-25
-2% -$13.2K 0.14% 68
2022
Q3 		$795K Buy
1,568
+11
+0.7% +$6.16K 0.14% 63
2022
Q2 		$846K Buy
1,557
+194
+14% +$107K 0.15% 66
2022
Q1 		$805K Buy
1,363
+731
+116% +$420K 0.14% 70
2021
Q4 		$422K Buy
632
+11
+2% +$6.87K 0.08% 102
2021
Q3 		$355K Buy
621
+74
+14% +$40.6K 0.08% 117
2021
Q2 		$276K Buy
547
+108
+25% +$51K 0.07% 137
2021
Q1 		$200K Buy
+439
New +$210K 0.06% 159

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PDS Planning's TMO Position: Q1 2026 in Review

PDS Planning increased its Thermo Fisher Scientific (TMO) stake by 4.4% in Q1 2026, buying an estimated $72.2K and bringing the position to 3,173 shares worth $1.56M. The position accounts for 0.1% of the portfolio, ranked #94.

PDS Planning first reported a position in TMO in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.76M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • PDS Planning held 3,173 shares of Thermo Fisher Scientific worth $1.56M as of Q1 2026.
  • PDS Planning bought 133 Thermo Fisher Scientific shares in Q1 2026, an estimated $72.2K.
  • Thermo Fisher Scientific made up 0.1% of PDS Planning's portfolio in Q1 2026, its #94 holding.
  • PDS Planning first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 21 quarters since.
  • PDS Planning's Thermo Fisher Scientific position peaked at $1.76M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on PDS Planning's 13F filing for Q1 2026, filed 22 Apr 2026.